This inventor holds 4 USPTO granted patents and 14 published patent applications and 5 EPO patents. Top assignees: Tau Medical Inc., The Asan Foundation, University of Ulsan Foundation for Industry Cooperation. Active years: 2022-2025.
Company Filing History:
3 out of 15 
2 out of 84 
1 out of 94 
Years Active: 2022-2025
Title: Innovations by Kyone Peter Park in Cardiac Treatment
Introduction
Kyone Peter Park is a notable inventor based in Yangsan, South Korea. He has made significant contributions to the field of cardiac treatment, particularly through his innovative patents. With a total of 4 patents, his work focuses on advanced medical devices aimed at treating hypertrophic cardiomyopathy.
Latest Patents
Kyone Peter Park's latest patents include groundbreaking technologies such as an RF ablation catheter designed for treating hypertrophic cardiomyopathy. This catheter features a flexible body made of soft material and an intraseptal insertion part equipped with electrodes and a tapered tip. The catheter is designed to be inserted into the interventricular septum along a guidewire, allowing for effective treatment. Another notable patent is the RF ablation catheter for septal reduction therapy, which incorporates a cooling effect to prevent tissue carbonization during the procedure. This innovative design enhances the safety and efficacy of the treatment for conditions like ventricular tachycardia.
Career Highlights
Throughout his career, Kyone Peter Park has worked with reputable organizations such as Tau Medical Inc. and The Asan Foundation. His experience in these companies has contributed to his expertise in developing advanced medical technologies.
Collaborations
Kyone Peter Park has collaborated with professionals like Gi-Byoung Nam and June Hong Kim, further enriching his work in the field of cardiac treatment.
Conclusion
Kyone Peter Park's contributions to medical innovation, particularly in the treatment of hypertrophic cardiomyopathy, highlight his role as a leading inventor in the field. His patents reflect a commitment to improving patient outcomes through advanced technology.